Treatment with antidepressant medications in private health plans

被引:18
|
作者
Larson, Mary Jo
Miller, Kay
Fleming, Kathleen J.
机构
[1] New England Res Inst Inc, Inst Hlth Serv Res, Watertown, MA 02472 USA
[2] Medstat, Santa Barbara, CA 93111 USA
[3] New England Res Inst Inc, Watertown, MA USA
关键词
antidepressants; utilization; expenditures; private insurance;
D O I
10.1007/s10488-006-0088-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study analyzed 2002 MarketScan data from a convenience sample of enrollees with private health insurance from the largest U.S. firms to examine utilization, expenditures, and factors associated with antidepressant prescriptions. Of enrollees, 11% received at least one antidepressant prescription during the year with average expenditures per enrollee of $51.55. Antidepressant prescriptions were more frequently used than any form of other mental health care and for 42% of users was not associated with any clearly identified mental health or "off-label" indication. In logistical regression analyses, health plan type, prescription days supply, gender, region, age, employment status, and subscriber status were associated with unexplained antidepressant prescription use.
引用
收藏
页码:116 / 126
页数:11
相关论文
共 50 条
  • [1] Treatment with Antidepressant Medications in Private Health Plans
    Mary Jo Larson
    Kay Miller
    Kathleen J. Fleming
    Administration and Policy in Mental Health and Mental Health Services Research, 2007, 34 : 116 - 126
  • [2] Availability of addiction medications in private health plans
    Horgan, Constance M.
    Reif, Sharon
    Hodgkin, Dominic
    Garnick, Deborah W.
    Merrick, Elizabeth L.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2008, 34 (02) : 147 - 156
  • [3] Management of Newer Antidepressant Medications in US Commercial Health Plans
    Hodgkin, Dominic
    Horgan, Constance M.
    Creedon, Timothy B.
    Merrick, Elizabeth L.
    Stewart, Maureen T.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 (04): : 165 - 173
  • [4] Antidepressant medication use in private insurance health plans, 2002
    Larson, MJ
    Miller, K
    Fleming, KJ
    PSYCHIATRIC SERVICES, 2006, 57 (02) : 175 - 175
  • [5] Management of access to branded psychotropic medications in private health plans
    Hodgkin, Dominic
    Horgan, Constance M.
    Garnick, Deborah W.
    Merrick, Elizabeth Levy
    Volpe-Vartanian, Joanna
    CLINICAL THERAPEUTICS, 2007, 29 (02) : 371 - 380
  • [6] Accessing Specialty Behavioral Health Treatment in Private Health Plans
    Merrick, Elizabeth L.
    Horgan, Constance M.
    Garnick, Deborah W.
    Reif, Sharon
    Stewart, Maureen T.
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2009, 36 (04): : 420 - 435
  • [7] Accessing Specialty Behavioral Health Treatment in Private Health Plans
    Elizabeth L. Merrick
    Constance M. Horgan
    Deborah W. Garnick
    Sharon Reif
    Maureen T. Stewart
    The Journal of Behavioral Health Services & Research, 2009, 36
  • [8] Health Economic Comparison of TMS and Antidepressant Medications in the Treatment of Major Depression
    Demitrack, Mark Andrew
    Bonneh-Barkay, Dafna
    Brock, David G.
    Waltman, Angela
    Nahas, Ziad
    Simpson, Kit N.
    Simpson, Annie N.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 45S - 46S
  • [9] The Public Health Impact of Antidepressant Medications
    Mojtabai, Ramin
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2007, 1 (01) : 2 - U100
  • [10] Getting into specialty substance abuse treatment in private health plans
    Merrick, E. L.
    Horgan, C. M.
    Garnick, D. W.
    Reif, S.
    Hodgkin, D.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (06) : 251A - 251A